Discover 2,242 paid clinical trials in San Jose, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
San Jose currently offers many active clinical trials with a particular emphasis on diabetes, Parkinson’s disease, Alzheimer’s disease, and cardiovascular conditions. Whether you’re looking for trials related to a specific health condition or interested in paid research as a healthy volunteer, San Jose’s diverse studies provide a variety of choices to explore new treatments while contributing to the future of medicine.
Filter
2
Filter results
Results: 2,242
SPL Insufficiency Syndrome (SPLIS)/NPHS14: a SPLIS Observational Study and Patient Registry (International)
for
Sphingolipidoses, Enzyme Deficiency
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 0+
Code: NCT04885179
Recruiting
SPIROMICS Study of Early COPD Progression (SOURCE)
for
COPD, Early-Onset
Location: San Francisco CA, Los Angeles CA, Salt Lake City UT,
Location: San Francisco CA, San Diego CA, Austin TX,
Sponsor: Indiana University
Sex: All
Age: 18+
Code: NCT05264779
Recruiting
International Registry of Patients With Alpha Thalassemia
for
Alpha-Thalassemia, Alpha Thalassemia Major,
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 0+
Code: NCT04872179
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
for
Lupus Nephritis
Location: San Francisco CA, Salt Lake City UT, Seattle WA,
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 8 - 20
Code: NCT05538208
Phase 2, Recruiting
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
for
Arrhythmogenic Right Ventricular Cardiomyopathy
Location: San Francisco CA, Aurora CO, Rochester MN, Cleveland OH,
Location: San Francisco CA, Houston TX, Cincinnati OH, Boston MA
Sponsor: Allison O'Neill, MD
Sex: All
Age: 0 - 30
Code: NCT04134559
Phase 2, Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Location: San Francisco CA, Los Angeles CA, Orange CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07221357
Phase 2, Phase 3, Recruiting
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
for
Glioblastoma
Location: San Francisco CA, Los Angeles CA, Scottsdale AZ,
Sponsor: GT Medical Technologies, Inc.
Sex: All
Age: 18+
Code: NCT07195591
Phase 3, Recruiting
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
for
Prostate Cancer
Location: San Francisco CA, Seattle WA, St Louis MO, Milwaukee WI,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT06613100
Phase 1, Recruiting
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance
for
Prostate Adenocarcinoma, Prostate Cancer
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: Male
Age: 18+
Code: NCT03933670
Phase 2, Recruiting
Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
for
Mantle Cell Lymphoma
Location: San Francisco CA, Davis CA, Los Angeles CA,
Sponsor: University of California, San Francisco
Sex: All
Age: 18+
Code: NCT06252675
Phase 2, Recruiting
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
for
Interstitial Lung Disease, Common Variable Immunodeficiency
Location: San Francisco CA, Rochester MN, Cincinnati OH,
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 4+
Code: NCT04925375
Phase 2, Recruiting
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
for
Solid Tumors Harboring MET Amplification
Location: Palo Alto CA, Los Angeles CA, Beverly Hills CA,
Sponsor: AbbVie
Sex: All
Age: 12+
Code: NCT07196644
Phase 2, Recruiting
Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma
for
Advanced Hepatocellular Carcinoma,
Location: San Francisco CA
Sponsor: Mary Feng, MD
Sex: All
Age: 18+
Code: NCT04430452
Phase 2, Recruiting
PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01)